Form 4 for NPCE NeuroPace Inc
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0001415889-25-005571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-25 | 2024-01-31 | NPCE | Morrell Martha | Chief MEDICAL Off | M - OptEx | $0.03 | +52.8K | 43.9K | New | +$1,584 |
| DM | 2025-02-25 | 2022-04-22+ | NPCE | Morrell Martha | Chief MEDICAL Off | F - Tax | $11.04 | -43.1K | 43.7K | -50% | -$475.7K |
| DM | 2025-02-25 | 2024-01-31 | NPCE | Morrell Martha | Chief MEDICAL Off | M - OptEx | $0.00 | -52.8K | 180.4K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-31 | M | A | 12,234 | $0.03 | 56,480 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-31 | M | A | 40,000 | $0.03 | 96,480 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-22 | F | D | 926 | $8.32 | 85,836 | D | — | — | |
| 4 | Common | Common Stock | 2022-07-22 | F | D | 231 | $5.55 | 85,605 | D | — | — | |
| 5 | Common | Common Stock | 2022-10-22 | F | D | 233 | $3.02 | 85,372 | D | — | — | |
| 6 | Common | Common Stock | 2023-01-22 | F | D | 264 | $2.98 | 85,108 | D | — | — | |
| 7 | Common | Common Stock | 2023-03-03 | F | D | 5,167 | $4.10 | 79,941 | D | — | — | |
| 8 | Common | Common Stock | 2023-04-22 | F | D | 231 | $4.25 | 79,710 | D | — | — | |
| 9 | Common | Common Stock | 2023-06-03 | F | D | 1,303 | $4.11 | 78,407 | D | — | — | |
| 10 | Common | Common Stock | 2023-07-22 | F | D | 231 | $4.13 | 78,176 | D | — | — | |
| 11 | Common | Common Stock | 2023-09-03 | F | D | 1,302 | $8.93 | 76,874 | D | — | — | |
| 12 | Common | Common Stock | 2023-10-22 | F | D | 231 | $6.88 | 76,643 | D | — | — | |
| 13 | Common | Common Stock | 2023-12-03 | F | D | 1,303 | $8.90 | 75,340 | D | — | — | |
| 14 | Common | Common Stock | 2024-01-22 | F | D | 264 | $14.84 | 75,076 | D | — | — | |
| 15 | Common | Common Stock | 2024-02-20 | F | D | 12,474 | $17.50 | 62,602 | D | — | — | |
| 16 | Common | Common Stock | 2024-03-03 | F | D | 1,334 | $15.99 | 61,031 | D | — | — | |
| 17 | Common | Common Stock | 2024-04-22 | F | D | 237 | $14.00 | 61,268 | D | — | — | |
| 18 | Common | Common Stock | 2024-05-20 | F | D | 3,045 | $7.98 | 57,986 | D | — | — | |
| 19 | Common | Common Stock | 2024-06-03 | F | D | 1,335 | $6.46 | 56,511 | D | — | — | |
| 20 | Common | Common Stock | 2024-07-22 | F | D | 237 | $7.65 | 56,414 | D | — | — | |
| 21 | Common | Common Stock | 2024-08-20 | F | D | 3,045 | $7.24 | 53,369 | D | — | — | |
| 22 | Common | Common Stock | 2024-09-03 | F | D | 1,334 | $7.39 | 52,035 | D | — | — | |
| 23 | Common | Common Stock | 2024-10-22 | F | D | 237 | $6.00 | 51,798 | D | — | — | |
| 24 | Common | Common Stock | 2024-11-20 | F | D | 3,045 | $9.19 | 48,753 | D | — | — | |
| 25 | Common | Common Stock | 2024-12-03 | F | D | 1,413 | $11.93 | 47,340 | D | — | — | |
| 26 | Common | Common stock | 2024-01-31 | M | A | 192 | $0.03 | 44,246 | D | — | — | |
| 27 | Common | Common Stock | 2024-01-31 | M | A | 192 | $0.03 | 44,054 | D | — | — | |
| 28 | Common | Common Stock | 2024-01-31 | M | A | 192 | $0.03 | 43,862 | D | — | — | |
| 29 | Common | Common Stock | 2025-01-22 | F | D | 265 | $14.04 | 47,075 | D | — | — | |
| 30 | Common | Common Stock | 2025-02-20 | F | D | 3,405 | $14.23 | 43,670 | D | — | — | |
| 31 | Derivative | Stock Option (Rt to Buy) | 2024-01-31 | M | D | 192 | $0.00 | 0 | D | $0.03 · — to 2030-11-30 | 192 Common Stock | (F1) 25% of the shares subject to the option vest on July 1, 2015; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter. |
| 32 | Derivative | Stock Option (Rt to Buy) | 2024-01-31 | M | D | 192 | $0.00 | 0 | D | $0.03 · — to 2030-11-30 | 192 Common Stock | (F3) 25% of the shares subject to the option vest on July 1, 2013; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter. |
| 33 | Derivative | Stock Option (Rt to Buy) | 2024-01-31 | M | D | 192 | $0.00 | 192 | D | $0.03 · — to 2030-11-30 | 192 Common Stock | (F4) 25% of the shares subject to the option vest on July 1, 2012; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter. |
| 34 | Derivative | Stock Option (Rt to Buy) | 2024-01-31 | M | D | 12,234 | $0.00 | 12,234 | D | $0.03 · — to 2030-11-30 | 12,234 Common Stock | (F5) 1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017. |
| 35 | Derivative | Stock Option (Rt to Buy) | 2024-01-31 | M | D | 40,000 | $0.00 | 180,449 | D | $0.03 · — to 2030-11-30 | 40,000 Common Stock | (F6) 1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017. |